GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment
Background: Previous in vitro study showed that Galectin-3 (Gal-3) protein plays an important role in pituitary tumorigenesis, however, the association of Gal-3 expression with the clinical feature and prognosis of pituitary tumor in a clinical setting remains unknown. Methods: We enrolled 220 patie...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2014-04-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/358673 |
_version_ | 1811267144366686208 |
---|---|
author | Dongwei Dai Ya'nan Li Qiong Lu Longyang Yu Weijie Min Laixing Wang Yiqun Cao Zhijian Yue |
author_facet | Dongwei Dai Ya'nan Li Qiong Lu Longyang Yu Weijie Min Laixing Wang Yiqun Cao Zhijian Yue |
author_sort | Dongwei Dai |
collection | DOAJ |
description | Background: Previous in vitro study showed that Galectin-3 (Gal-3) protein plays an important role in pituitary tumorigenesis, however, the association of Gal-3 expression with the clinical feature and prognosis of pituitary tumor in a clinical setting remains unknown. Methods: We enrolled 220 patients with prolactin-secreting pituitary adenomas (PA) who previously had transsphenoidal pituitary surgery. The Gal-3 expression was detected in the patients' PA samples using immunohistochemistry and those patients were followed up. A prolactin-secreting PA cell line, the MMQ cell line, was used to study the in vitro effect of Gal-3 on proliferation, migration and invasion of PA cells using small interfering RNA (siRNA) transfecton technique. The in vivo tumorgenesis in nude mice was also studied. Results: We found that Gal-3 expression was not related to age and sex, but positively associated with tumor invasion (Pin vitro studies showed that Gal-3 knock-down by the siRNA technique significantly inhibited the proliferation, migration and invasion ability of the MMQ cells, whereas Gal-3 siRNA transfection induced apoptosis of the MMQ cells. The in vivo tumorgenesis assay showed that Gal-3 siRNA transfection significantly inhibited the tumor volume in vivo compared to transfection of the control siRNA (PConclusion: Gal-3 regulates proliferation, apoptosis, migration and invasion of the MMQ cells. Gal-3 may be used as a tissue marker to evaluate the clinical feature and prognosis of PA patients. |
first_indexed | 2024-04-12T20:56:07Z |
format | Article |
id | doaj.art-aa4b93aa9b6c416781789115cb1fab86 |
institution | Directory Open Access Journal |
issn | 1015-8987 1421-9778 |
language | English |
last_indexed | 2024-04-12T20:56:07Z |
publishDate | 2014-04-01 |
publisher | Cell Physiol Biochem Press GmbH & Co KG |
record_format | Article |
series | Cellular Physiology and Biochemistry |
spelling | doaj.art-aa4b93aa9b6c416781789115cb1fab862022-12-22T03:16:59ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782014-04-013341026103510.1159/000358673358673GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical TreatmentDongwei DaiYa'nan LiQiong LuLongyang YuWeijie MinLaixing WangYiqun CaoZhijian YueBackground: Previous in vitro study showed that Galectin-3 (Gal-3) protein plays an important role in pituitary tumorigenesis, however, the association of Gal-3 expression with the clinical feature and prognosis of pituitary tumor in a clinical setting remains unknown. Methods: We enrolled 220 patients with prolactin-secreting pituitary adenomas (PA) who previously had transsphenoidal pituitary surgery. The Gal-3 expression was detected in the patients' PA samples using immunohistochemistry and those patients were followed up. A prolactin-secreting PA cell line, the MMQ cell line, was used to study the in vitro effect of Gal-3 on proliferation, migration and invasion of PA cells using small interfering RNA (siRNA) transfecton technique. The in vivo tumorgenesis in nude mice was also studied. Results: We found that Gal-3 expression was not related to age and sex, but positively associated with tumor invasion (Pin vitro studies showed that Gal-3 knock-down by the siRNA technique significantly inhibited the proliferation, migration and invasion ability of the MMQ cells, whereas Gal-3 siRNA transfection induced apoptosis of the MMQ cells. The in vivo tumorgenesis assay showed that Gal-3 siRNA transfection significantly inhibited the tumor volume in vivo compared to transfection of the control siRNA (PConclusion: Gal-3 regulates proliferation, apoptosis, migration and invasion of the MMQ cells. Gal-3 may be used as a tissue marker to evaluate the clinical feature and prognosis of PA patients.http://www.karger.com/Article/FullText/358673Galectin-3Pituitary adenomasPrognosis |
spellingShingle | Dongwei Dai Ya'nan Li Qiong Lu Longyang Yu Weijie Min Laixing Wang Yiqun Cao Zhijian Yue GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment Cellular Physiology and Biochemistry Galectin-3 Pituitary adenomas Prognosis |
title | GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment |
title_full | GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment |
title_fullStr | GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment |
title_full_unstemmed | GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment |
title_short | GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment |
title_sort | gal3 protein expression is related to clinical features of prolactin secreting pituitary microadenoma and predicts its recurrence after surgical treatment |
topic | Galectin-3 Pituitary adenomas Prognosis |
url | http://www.karger.com/Article/FullText/358673 |
work_keys_str_mv | AT dongweidai gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment AT yananli gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment AT qionglu gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment AT longyangyu gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment AT weijiemin gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment AT laixingwang gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment AT yiquncao gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment AT zhijianyue gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment |